Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01313442 · ClinicalTrials.gov registry record
Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
A clinical trial of Gastrointestinal Cancer and Cancer of Gastrointestinal Tract, sponsored by National Cancer Institute (NCI).
- Recruiting
- Registry status
- 550
- Enrollment target
- 1
- Study location
NCT01313442 is a study of Gastrointestinal Cancer and Cancer of Gastrointestinal Tract that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 550 participants, above the 222-participant average among 48 other Gastrointestinal Cancer trials with a reported enrollment target (148% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01313442, a study of Gastrointestinal Cancer and Cancer of Gastrointestinal Tract, is actively recruiting participants, sponsored by National Cancer Institute (NCI).
- RECRUITING
- Registry status
- 550 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Gastrointestinal cancers can occur in the throat, stomach, gallbladder, liver, pancreas, and colon. Researchers are interested in evaluating how active the immune system is in trying to fight the cancer by studying blood and tumor tissue donated from individuals who have been diagnosed with gastrointestinal cancers. Objectives: \- To collect blood and tumor samples from individuals who have been diagnosed with gastrointestinal cancers in order to study the immune system s response to the cancer. Eligibility: \- Individuals at least 18 years of age who have been diagnosed with throat, stomach, gallbladder, liver, pancreatic, or colon cancer, and are scheduled to be treated at the National Institutes of Health. Design: * The study will require at least one but no more than four visits to the National Institutes of Health Clinical Center. * Participants will be screened with a physical examination and medical history, and will provide a baseline blood sample for study. * Participants will provide additional blood samples 2 and 4 months after the baseline sample, as well as a final sample at the completion of the treatment protocol. * Participants will provide tumor tissue samples only if they undergo a surgical procedure related to the treatment for their gastrointestinal cancer. * No treatment will be provided as part of this protocol.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2011-03-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01313442
The ClinicalTrials.gov registry entry for NCT01313442 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 222-participant average among 48 other Gastrointestinal Cancer trials with a reported enrollment target (148% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Gastrointestinal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01313442 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01313442 about?
NCT01313442 is a clinical study titled "Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer". Background: \- Gastrointestinal cancers can occur in the throat, stomach, gallbladder, liver, pancreas, and colon. Researchers are interested in evaluating how active the immune system is in trying to fight the cancer by studying blood and tumor tissue donated from individuals who have been diagnos...
What is the current status of trial NCT01313442?
This trial is currently recruiting. The enrollment target is 550 participants. The study started on 2011-03-02.
What conditions does trial NCT01313442 study?
This clinical trial studies the following conditions: Gastrointestinal Cancer, Cancer of Gastrointestinal Tract, Non-GI Cancers.
Who is sponsoring clinical trial NCT01313442?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01313442 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
Improving Comprehensive Care of Cancer Patients
RECRUITING · NA
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.